State Of Wisconsin Investment Board Apellis Pharmaceuticals, Inc. Transaction History

State Of Wisconsin Investment Board

$37.8 Billion
Q3 2024

A detailed history of State Of Wisconsin Investment Board transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 81,039 shares of APLS stock, worth $2.31 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

81,039

Previous 77,349 4.77%

Holding current value

$2.31 Million

Previous $2.97 Million 21.23%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$28.84 - $41.15 $106,419 - $151,843	3,690 Added 4.77%	81,039 $2.34 Million
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $977,409 - $1.53 Million	25,674 Added 49.68%	77,349 $2.97 Million
Q1 2024 May 14, 2024	SELL	$55.39 - $72.47 $893,440 - $1.17 Million	-16,130 Reduced 23.79%	51,675 $3.04 Million
Q4 2023 Feb 12, 2024	SELL	$37.14 - $64.82 $555,874 - $970,160	-14,967 Reduced 18.08%	67,805 $4.06 Million
Q3 2023 Nov 14, 2023	BUY	$23.65 - $89.22 $140,764 - $531,037	5,952 Added 7.75%	82,772 $3.15 Million
Q2 2023 Aug 14, 2023	SELL	$76.68 - $93.31 $365,303 - $444,528	-4,764 Reduced 5.84%	76,820 $7 Million
Q1 2023 May 15, 2023	SELL	$46.59 - $66.96 $306,282 - $440,195	-6,574 Reduced 7.46%	81,584 $5.38 Million
Q4 2022 Feb 14, 2023	BUY	$43.24 - $61.04 $301,296 - $425,326	6,968 Added 8.58%	88,158 $4.56 Million
Q3 2022 Nov 14, 2022	SELL	$44.76 - $69.66 $86,207 - $134,165	-1,926 Reduced 2.32%	81,190 $5.55 Million
Q2 2022 Aug 15, 2022	SELL	$35.07 - $59.21 $441,320 - $745,098	-12,584 Reduced 13.15%	83,116 $3.76 Million
Q4 2021 Feb 11, 2022	BUY	$30.74 - $49.16 $175,218 - $280,212	5,700 Added 6.33%	95,700 $4.53 Million
Q3 2021 Nov 12, 2021	BUY	$31.4 - $69.84 $285,740 - $635,544	9,100 Added 11.25%	90,000 $2.97 Million
Q1 2021 May 17, 2021	SELL	$40.8 - $57.39 $191,760 - $269,733	-4,700 Reduced 5.49%	80,900 $3.47 Million
Q4 2020 Feb 03, 2021	SELL	$30.79 - $57.2 $329,453 - $612,040	-10,700 Reduced 11.11%	85,600 $4.9 Million
Q2 2020 Aug 12, 2020	SELL	$24.8 - $38.49 $2.43 Million - $3.77 Million	-98,005 Reduced 50.44%	96,300 $3.15 Million
Q1 2020 May 06, 2020	BUY	$17.91 - $44.33 $2.19 Million - $5.41 Million	122,105 Added 169.12%	194,305 $5.21 Million
Q3 2019 Nov 12, 2019	BUY	$24.09 - $32.18 $486,618 - $650,036	20,200 Added 38.85%	72,200 $1.74 Million
Q2 2019 Aug 14, 2019	BUY	$18.0 - $25.34 $19,800 - $27,874	1,100 Added 2.16%	52,000 $1.32 Million
Q1 2019 May 13, 2019	BUY	$12.81 - $19.82 $176,778 - $273,516	13,800 Added 37.2%	50,900 $993,000
Q4 2018 Feb 11, 2019	BUY	$11.47 - $18.71 $3,441 - $5,613	300 Added 0.82%	37,100 $489,000
Q2 2018 Aug 03, 2018	BUY	$19.63 - $30.0 $722,384 - $1.1 Million	36,800 New	36,800 $810,000

Others Institutions Holding APLS

# of Institutions

301

Shares Held

112M

Call Options Held

3.85M

Put Options Held

1.09M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.13B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account

State Of Wisconsin Investment Board Apellis Pharmaceuticals, Inc. Transaction History